Growth Metrics

Anaptysbio (ANAB) Income from Continuing Operations (2016 - 2025)

Anaptysbio filings provide 10 years of Income from Continuing Operations readings, the most recent being 62682000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Income from Continuing Operations rose 385.92% year-over-year to 62682000.0, compared with a TTM value of 164000.0 through Dec 2025, up 99.89%, and an annual FY2025 reading of 164000.0, up 99.89% over the prior year.
  • Income from Continuing Operations hit 62682000.0 in Q4 2025 for Anaptysbio, up from 15113000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 121369000.0 in Q4 2023, with the low at 46660000.0 in Q2 2024.
  • Median Income from Continuing Operations over the past 5 years was 29230000.0 (2021), compared with a mean of 15261000.0.
  • The sharpest move saw Income from Continuing Operations crashed 6121.91% in 2022, then skyrocketed 648.34% in 2023.
  • Year by year, Income from Continuing Operations stood at 31089000.0 in 2021, then grew by 28.8% to 22134000.0 in 2022, then soared by 648.34% to 121369000.0 in 2023, then crashed by 118.06% to 21923000.0 in 2024, then surged by 385.92% to 62682000.0 in 2025.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 62682000.0, 15113000.0, and 38630000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.